Rheumatology

Latest News

$Because serum analysis is already used to diagnose RA, track its progression, and understand response to therapy, the authors investigated whether reliable biomarkers could be found for refractory RA. | Image credit: angellodeco - stok.adobe.com$

Serum Biomarkers for Refractory Active Rheumatoid Arthritis Remain Elusive

By Jared Kaltwasser

April 28th 2025

New research suggests classical biomarkers cannot discriminate between refractory and non-refractory rheumatoid arthritis.

Using Telemedicine Interventions During COVID-19 to Expand Care Post COVID-19

By Kjel A. Johnson, PharmD
Chip Parkinson, BS

January 24th 2023

A graphic with the title and health icons

Top 5 Most-Read Rheumatology Articles of 2022

By Justina Petrullo

January 1st 2023

picture of cannabis leaf

Cannabis Improves Quality of Life in Women With Treatment-Resistant Fibromyalgia

December 14th 2022

graphic depicting immune system

Stopping Methotrexate for 1 Week After Flu Vaccine May Work as Well as 2 Weeks

December 1st 2022

More News

Pathophysiology of Autoimmune Diseases and Inflammation

November 26th 2018

Pathophysiology of Autoimmune Diseases and Inflammation

Ultrasound Safer Than MRI to Monitor Rheumatoid Arthritis in Pregnancy

November 20th 2018

Ultrasound Safer Than MRI to Monitor Rheumatoid Arthritis in Pregnancy

David Bai, PharmD

Ultrasounds are a safer and equally effective diagnostic tool compared with magnetic resonance imaging (MRI) to diagnose and monitor pregnant women with suspected active rheumatoid arthritis (RA), according to a new report published in Radiology Case Reports.

July 12th 2018

Two-Year Adherence and Costs for Biologic Therapy for Rheumatoid Arthritis

Bradley S. Stolshek, PharmD Sally Wade, MPH Alex Mutebi, PhD, MSc Ajita P. De, MA, MPhil, MS Rolin L. Wade, MS Jason Yeaw, MPH

Adherence to newly initiated biologic therapy for rheumatoid arthritis is important for long-term adherence.

Switching Method of Action in RA Treatment After Anti-TNF Failure Associated With Lower Healthcare Costs

January 10th 2018

Switching Method of Action in RA Treatment After Anti-TNF Failure Associated With Lower Healthcare Costs

When patients with rheumatoid arthritis experience failure of an anti–tumor necrosis factor (anti-TNF) therapy, clinical guidelines support either cycling to a different anti-TNF agent or switching to a treatment with a different method of action (MOA). However, payers often require cycling of anti-TNF options before they will reimburse for treatments with a different MOA.

Biologics Associated With Lower Overall Risk of Malignancy in Patients With Early RA

January 3rd 2018

Biologics Associated With Lower Overall Risk of Malignancy in Patients With Early RA

In a new study, published in Arthritis Research & Therapy, a research team led by Soo-Kyung Cho, MD, sought to investigate the incidence of malignancy in early rheumatoid arthritis and found that the use of biologic disease-modifying anti-rheumatic drugs decreased the overall risk of developing malignancies, though it did not affect the risk of developing hematologic malignancies.

November 8th 2017

Federal Agencies Address the Dual Crises of Pain and Opioid Addiction

In a Tuesday panel discussion at The American College of Rheumatology’s 2017 Annual Meeting in San Diego, California, representatives from HHS, the National Institutes of Health (NIH), and the CDC outlined ongoing federal initiatives to address the parallel problems of pain and opioid addiction.

November 8th 2017

ACR and NPF Unveil New Clinical Guideline for Treating Psoriatic Arthritis

On Tuesday afternoon, the American College of Rheumatology (ACR) and the National Psoriasis Foundation (NPF) presented a draft of their new, jointly developed clinical guideline for treating psoriatic arthritis (PsA), at the ACR 2017 Annual Meeting.

November 7th 2017

Rheumatology Patients at Increased Risk for Cardiac Disease

During a session at the 2017 American College of Rheumatology Annual Meeting in San Diego, California, a cardiologist joined rheumatologists to give a detailed look at the relationship between rheumatic conditions and cardiovascular disease.

September 21st 2017

Certain Occupations Associated With an Increased Risk of Rheumatoid Arthritis

Alison Rodriguez

Occupations related to potential noxious airborne agents are related to an increased risk of rheumatoid arthritis (RA), according to recent research.

January 20th 2017

Exclusive Coverage of the American College of Rheumatology Annual Meeting Washington, DC November 11-16, 2016

November 16th 2016

Online Support Tools Teach Self-Management for Teens With Juvenile Arthritis

Christina Mattina

At the Annual Meeting of the American College of Rheumatology in Washington, DC, several experts presented their progress in harnessing technology to help teenagers and young adults manage their juvenile arthritis.

November 13th 2016

MACRA: Putting Together the Pieces for Practice

Be careful what you wish for:Â SGR and FFS will be models of the past; the success of the APM and MIPS will rely on compensation, collaboration and participation; and, to date, much remains to be done in the development of quality-based payment reform under MACRA.Â

November 13th 2016

Getting Telehealth Right: Engaging Patients and Providers

Telehealth broadly is about creating care connections across boundaries, care that encourages patients’ independence, prevention and wellness; and care that can be leveraged for needed interventions. If we get telehealth right we can reduce impact of what we know is a growing health workforce shortage and concurrently create a healthier, more engaged patient base.

April 30th 2014

Early Diagnosis Key to Getting Rheumatoid Arthritis Patients to 'Target, Leading Academic Physicians Agree

Two leading academic rheumatologists who took part in a live discussion with A. Mark Fendrick, MD, co-editor-in-chief of The American Journal of Managed Care, agreed that getting an accurate early diagnosis of rheumatoid arthritis (RA) is key to getting the patient started on disease modifying therapy. Today's goal, they said, is remission of the disease, not just managing symptoms.

July 14th 2011

Impact of Celecoxib Restrictions in Medicare Beneficiaries With Arthritis

Anthony M. Louder, PhD, RPh Ashish V. Joshi, PhD Amy T. Ball, PharmD Joseph C. Cappelleri, PhD Michael C. Deminski, MS, RPh Robert J. Sanchez, PhD

A formulary restriction policy in a Medicare population was associated with lower celecoxib utilization; however, higher gastrointestinal- and arthritis-related medical costs were observed.

December 1st 2007

The Future of Outcomes Measurement in Rheumatology

Robert M. Kaplan, PhD

ACR Supports Continued Use of Telemedicine and Reimbursement Parity After COVID-19 Crisis

December 1st 1997

ACR Supports Continued Use of Telemedicine and Reimbursement Parity After COVID-19 Crisis

Laura Joszt, MA

The widespread adoption of telemedicine during the coronavirus disease 2019 (COVID-19) pandemic, as well as reimbursement parity that was enacted by CMS, should be continued once the public health emergency passes, according to a new position statement by the American College of Rheumatology (ACR).

...

6 7 8 9 10 11 >

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions